David R. Webb*, Kurt Jarnagin and Sujan Shresta
The continuing COVID-19 pandemic, caused by SARS-CoV-2, has spurred heightened urgency for new therapeutics. In turn this has underscored the need for better animal models to use for both research and development. A recent commentary in Biochemical Pharmacology by Jarnagin et al. has proposed a three gene humanized mouse model to serve this need.
